Perioperative antimicrobial prophylaxis in clean-contaminated head and neck squamous cell cancer surgeries: Is less better?

被引:1
|
作者
Kohli, Pavneet [1 ]
Penumadu, Prasanth [1 ]
Shukkur, Naveeth [1 ]
Sivasanker, M. [3 ]
Balasubramanian, Arumugam [1 ]
Ganapathy, Sachit [2 ]
机构
[1] JIPMER, Dept Surg Oncol, Pondicherry, India
[2] JIPMER, Dept Biostat, Pondicherry, India
[3] Royal Liverpool Univ Hosp NHS Trust, Dept Surg, Liverpool, Merseyside, England
关键词
Antibiotic misuse; antibiotic resistance; clean-contaminated surgery; head and neck surgery; oral cancer; SSI; SURGICAL SITE INFECTIONS; ANTIBIOTIC-PROPHYLAXIS; ONCOLOGIC SURGERY; SHORT-TERM; COMPLICATIONS; PREVENTION; CLASSIFICATION; METRONIDAZOLE; CLINDAMYCIN; CEFAZOLIN;
D O I
10.4103/jcrt.JCRT_1654_20
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Judicious use of antibiotics and stringent adherence to practice guidelines is the need of the hour as antibiotic resistance is a rampant problem. Despite several reports in the literature describing the optimal duration of antibiotics, there is no consensus. A "one for all" protocol may be impractical and hence the guidelines need to be tweaked to take into consideration local factors. We designed a protocol for prophylactic antibiotics in clean-contaminated head and neck cancer squamous cell carcinoma (HNSCC) surgeries to prevent unchecked abuse and evaluated its feasibility. Materials and Methods: Two hundred consecutive patients who underwent a clean-contaminated surgery for HNSCC between January 2017 and December 2019 were included. Single-dose intravenous amoxicillin-clavulanate at induction followed by three doses of amoxicillin-clavulanate, metronidazole, and amikacin in the postoperative period was used. Adherence to the antibiotic protocol was assessed from a prospectively maintained database. Results: The mean age was 55.99 +/- 11.71 years. The protocol was effective in 70% of the patients with an acceptable surgical site infection (SSI) rate of 12%. Flap-related complications (9.5%) and oro-cutaneous fistula (5%) were common causes of prolonged antibiotics. On univariate analysis, blood transfusion (P =.014), clinical stage at presentation (P =.028), patients undergoing reconstruction (P =.001), longer operative time (P =.009), and pathological T stage (P = 0.03) were at higher chance of deviating from the protocol. On multivariate analysis, age more than 50 years (OR: 2.14, 95% CI: (1.01, 4.52); P value = 0.047) and reconstruction (OR: 3.36, 95% CI: (1.21, 9.32); P value = 0.020) were found to be significant. Conclusions: A three-dose perioperative antibiotic prophylaxis in clean-contaminated HNSCC surgeries is feasible. Similar protocols should be developed and validated at other major centers to limit the unnecessary use of antibiotics and prevent the emergence of antibiotic resistance.
引用
收藏
页码:S170 / S176
页数:7
相关论文
共 50 条
  • [31] Cetuximab and the Head and Neck Squamous Cell Cancer
    Concu, Riccardo
    Cordeiro, M. Natalia D. S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (03) : 192 - 198
  • [32] Immunotherapy in Head and Neck Squamous Cell Cancer
    Denaro, Nerina
    Merlano, Marco Carlo
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2018, 11 (04) : 217 - 223
  • [33] Perioperative Survival of Elderly Head and Neck Squamous Cell Carcinoma Patients
    Stokes, William A.
    Fuller, Collin
    Day, Terry A.
    Gillespie, Marion B.
    LARYNGOSCOPE, 2014, 124 (10): : 2281 - 2286
  • [34] Surgical site infection in clean-contaminated wounds after multimodal treatment of advanced oral squamous cell carcinoma
    Eder-Czembirek, Christina
    Czembirek, Cornelia
    Braun, Pamela
    Perisanidis, Christos
    Seemann, Rudolf
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2016, 44 (12) : 1957 - 1962
  • [35] Hyponatremia and perioperative complications in patients with head and neck squamous cell carcinoma
    Feinstein, Aaron J.
    Davis, John
    Gonzalez, Lyndon
    Blackwell, Keith E.
    Abemayor, Elliot
    Mendelsohn, Abie H.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1370 - E1374
  • [36] The role of antimicrobial prophylaxis in patients with head and neck cancer undergoing chemoradiation
    Jaeger, Alina T.
    Connelly, James E.
    Jin, Ruyun
    Jacobson, Samuel N.
    Leidner, Rom S.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) : 580 - 586
  • [37] Head and Neck Squamous Cell Carcinoma of Unknown Primary: Is There a Better Treatment?
    Nguyen, N.
    Hodson, D.
    Zhang, H.
    Doerwald-Munoz, L. E.
    Jim, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S570 - S570
  • [38] Cancer stem cells in head and neck squamous cell cancer
    Prince, Mark E. P.
    Ailles, Laurie E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (17) : 2871 - 2875
  • [39] Association between perioperative allogeneic red blood cell transfusion and infection after clean-contaminated surgery: a retrospective cohort study
    Xu, Xiaohan
    Zhang, Yuelun
    Gan, Jia
    Ye, Xiangyang
    Yu, Xuerong
    Huang, Yuguang
    BRITISH JOURNAL OF ANAESTHESIA, 2021, 127 (03) : 405 - 414
  • [40] Serum Biomarkers in Head and Neck Squamous Cell Cancer
    Kaskas, Nadine M.
    Moore-Medlin, Tara
    McClure, Gloria B.
    Ekshyyan, Oleksandr
    Vanchiere, John A.
    Nathan, Cherie-Ann O.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 140 (01) : 5 - 11